GreenLight Biosciences Holdings
GreenLight Biosciences Holdings (GRNA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GRNA · as of Jun 9, 2026
Key Statistics
Explore GreenLight Biosciences Holdings Data
grna stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 50.0%
The GRNA analyst consensus is Buy, based on ratings from 2 Wall Street analysts over the past 3 months. The average 12-month price target is $11.00, representing +3572.79% upside from the current price of $0.30.
Competitors & Peers
grna competitorsGRNA
ALVR
BLUE
ERYP
LIANY
MGTAStock Performance
Full HistoryAbout GreenLight Biosciences Holdings
GreenLight Biosciences Holdings is a biotechnology firm focused on developing and commercializing ribonucleic acid (RNA) solutions. Its innovative products serve both the human health and agricultural…
what is greenlight biosciences holdings · grna stock overview · greenlight biosciences holdings company profile · who is greenlight biosciences holdings ceo · grna NASDAQ · greenlight biosciences holdings headquarters · greenlight biosciences holdings business segments
About Stock Overview & Key Data
GreenLight Biosciences Holdings (GRNA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 3, 2022. As of the latest trading session, GRNA stock price is $0.30, with a market capitalization of $45.4M. The stock has returned -92.26% over the past 12 months and -73.96% year-to-date.
According to 2 Wall Street analysts, the consensus rating for GreenLight Biosciences Holdings stock is Buy, with an average 12-month price target of $11.00. In fiscal year 2022, GreenLight Biosciences Holdings reported revenue of $6.4M and net income of -$167.1M. For detailed data — including GreenLight Biosciences Holdings revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, GreenLight Biosciences Holdings (GRNA) stock price is $0.30. The stock is traded on NASDAQ under the ticker symbol GRNA. The 52-week range is $0.18 – $5.90.